Call for Abstracts and Submission Guidelines

Late Breaker Abstract Submissions Are Now Closed

If you have any questions regarding your abstract submission, please contact Hypertension 2010 abstract team at hypertension2010@abstractserver.com

Click on the links below to go directly to any of the following sections:

Call for Abstracts
Summary of Abstract Guidelines
Abstract Preparations
Abstract Blinding and Review
Abstract Notification and Presentation Guidelines
Accreditation

Call for Abstracts

Hypertension 2010 invites you to submit an abstract (s) for poster or oral presentations under the following categories:

1	Ambulatory Blood Pressure Monitoring
2	Adipocytokines
3	Aging
4	Aldosterone and Other Mineralocorticoids
5	Antihypertensive Drugs
6	Antihypertensive drugs and Orthostatic Intolerance
7	Arrhythmias
8	Arterial Stiffness and Pulse Wave Velocity
9	Atherosclerosis
10	Behavior and Behavior Modification
11	Blood Pressure Devices
12	BP Control in Primary Care
13	BP Measurements
14	Brain and Hypertension
15	Cardiac Consequences - Arrhythmias
16	Cell Growth and Apoptosis
17	Children and adolescents
18	Clinical Trials
19	Cognitive Function and Hypertension
20	Community Control of Hypertension
21	Compliance with Therapy
22	Coronary Artery Disease
23	Cost Utility of the BP Control Program
24	Development
25	Devices
26	Diabetes Mellitus
27	Diet and Hypertension
28	Disease Management
29	Drug
30	Educational programs
31	Endocrine Hypertension
32	Endothelial Dysfunction
33	Environmental Factors in Hypertension
34	Epidemiology of Hypertension
35	Ethnicity and Hypertension
36	Evolutionary medicine
37	Gene Targeting and Gene Regulation
38	Genetics of Cardiovascular disease
39	Genetics of Experimental Hypertension
40	Genetics of Human Hypertension
41	Genomics and proteomics
42	Guidelines for Management of Hypertension
43	Health Policy
44	Healthcare Delivery
45	Heart Failure
46	Hemodynamics
47	Home BP
48	Hypertension in Developing Countries
49	Hypertension in the Elderly
50	Hypertension in Women
51	Hypertension in Workplace
52	Hypertension Prevention and Control
53	Imaging Techniques in Hypertension
54	Inflammation
55	Insulin Resistance
56	Ion Transport and Cell Calcium Handling
57	Kidney and Hypertension
58	Left Ventricular Hypertrophy
59	Lifestyle Modifications
60	Lipid Metabolism
61	Lipids and Lipoproteins
62	Membrane Receptors
63	Metabolic Syndrome
64	Microcirculation in Hypertension
65	New Cardiovascular, Metabolic Drug Discovery
66	Nitric Oxide
67	Nursing and Hypertension
68	Nutrition
69	Obesity
70	Oxidative Stress and Antioxidants
71	Peripheral Artery Disease
72	Pharmacogenomics
73	Physical Activity and Hypertension
74	Population Health
75	Pregnancy Associated Hypertension
76	Prevention of Hypertension
77	Pulmonary Hypertension
78	Public health
79	Quality of Life
80	Renal disease
81	Renin-Angiotensin System
82	Renovascular Hypertension
83	Risk Factors of Cardiovascular Diseases
84	Salt and Hypertension
85	Signal Transduction
86	Sleep and Hypertension
87	Small Vessels Disease
88	Smoking and Hypertension
89	Stem Cell
90	Stroke
91	Surrogate Markers of Hypertensive Organ
92	Sympathetic Nervous System and Autonomic dysfunction
93	Transplantation
94	Target organ damage
95	Telehealth or Telemedicine
96	Therapeutic trials
97	Thromboembolism
98	Vascular Calcification
99	Vascular Disease
100	Vasoactive Peptides

Summary of Abstract Submission Guidelines

Please follow the submission guidelines closely:

The abstracts must not have been published before. All accepted abstracts will be published in a scientific journal (details to be advised when available).
Abstracts should be, clear, concise and written in English.
Abstracts can only be submitted online via the conference website http://www.vancouverhypertension2010.com/
The length of an abstract body should not exceed 2000 characters (about 300 words).
Figures and tables can be included under the following conditions:
- Tables:
  - Maximum of one table per abstract.
  - One table row = deduction of 50 characters
- Figures:
  - Maximum of three figures per abstract
  - One picture = deduction of 500 characters
Only submissions completed prior to the posted deadline will be considered.
Duplicate abstracts are not allowed. Submitted abstracts that contain similar or duplicate information from the same authors and institution will be disqualified.
Always check the final abstract with the system’s preview function before submission, and edit or replace as necessary. It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
An author should choose a preferred presentation type (oral or poster) with the system’s submission function and acknowledge that there are no guarantees it will become an oral presentation in the final program.
An author must choose at least one category (maximum of three categories) for each abstract.
The submission of an abstract carries with it the obligation that it will be presented at the meeting by the presenting author.
Abstract data or presenting author modification will not be allowed after April 1, 2010 for abstracts submitted prior to this date. Abstract data or presenting author modification will not be allowed after June 30 for Late Breaker abstracts.
To withdraw an abstract, the author must send an email request along with the abstract reference number to hypertension2010@abstractserver.com by June 30, 2010.
If you have any questions regarding your abstract submission, please contact Hypertension 2010 abstract team at hypertension2010@abstractserver.com
Rule of Two: An author may present a maximum of two abstracts at the conference, however, the number of submissions is not limited.
The first, last name and email address of each presenting author must be identical if it appears on more than one abstract.
All presenting authors must be registered by June 9, 2010 for regular abstracts and August 4, 2010 for late breaker abstracts.
Modification of presenting authors name will not be allowed after June 30, 2010.

Abstract Preparation

Once you created an account in the system, you can submit one or several abstracts from your account. After an abstract has been created, modifications can be made until the abstract submission deadline. No modifications can be made once the abstract has been submitted. Please note that you cannot create an account if you already created one for the hypertension 2008. If you need to retrieve your user name and password, please click on lost/forgotten password when signing in to the submission page.

Abstract category: The abstract category is the general heading under which your abstract will be reviewed and later published if accepted. Choose at least one abstract category (maximum of three categories) which best describes the subject of your abstract. Click here to view the complete list of categories.
Abstract title: The abstract title must indicate the nature of the investigation with no abbreviations or author/ institution names
Abstract body: The text of the abstract should briefly state the objective, methods, result and conclusion of the study.
- The abstract body must not exceed 2000 characters (around 300 words).
- Do not include any personal information of authors in the abstract body
- Graphics and tables can be added within the body and will count towards the total number of words. A graph (JPG, GIF, or PNG) equals 500 characters, a table equals 50 characters per row.
- Do not include any grant names or references in your abstract body
- Authors will be able to modify the abstract when it is in Draft status only. Make sure to proof read your abstract before submission.
Authors: All authors must be entered in the appropriate fields within the system’s Authors function.
- Rule of Two: Each presenting author or first author may present a maximum of two abstracts at the conference. The number of submissions is however not limited. Should an author have more than two abstracts accepted, a co-author must be named as presenting author for one or more abstracts.
- Co-authors name must not be entered in the study group section. Author names that are entered in this field will be discarded.
Preview: Always check the final abstract with the system’s preview function before submission, and edit or replace as necessary. It is the author’s responsibility to submit a correct abstract. Any errors in spelling, grammar or scientific fact will be reproduced as typed by the author.
Submission: Choose a preferred presentation type (oral or poster) with the system’s submission function and fill out the appropriate sections of the disclosure agreement.

Abstract Blinding and Review

All submitted abstracts will go through a blind review process carried out by an international reviewing committee. Each abstract will be reviewed by at least three reviewers.

Abstract Notification and Presentation Guidelines

Notification of abstract acceptance or rejection for early abstract submissions will be sent October 30, 2009, December 30, 2009 and April 30, 2010. Notification regarding abstract status i.e. oral or poster presentation as well as the presentation guidelines will be sent by the end of May 2010. Notification for Late Breaker abstracts will be sent by July 21, 2010.

Please note that only the corresponding author will receive mail concerning the abstract and is responsible for informing all co-authors of the status of the abstract. Authors whose abstracts have been accepted will receive instructions for the presentation of their abstract.

Abstract Submissions Are Now Closed

Accreditation

The Meeting is in the process of applying for accreditation. The status of Section 1, Mainpro M1 and AMA PRA 1 credits are to be advised.

If you have any questions regarding your abstract submission, please contact Hypertension 2010 abstract team at hypertension2010@abstractserver.com

Speaker Disclosure Form (PDF)

^ top